Leidos (LDOS) Acquires IMX To Expand Health Business
Zacks Investment Research | Aug 15, 2019 09:48PM ET
Leidos Holdings Inc. (NYSE:LDOS) announced that it has completed the acquisition of IMX Medical Management Services (“IMX”) and its affiliated businesses. IMX will complement the medical services provided by QTC Management, Inc. (“QTC”), which is a wholly-owned subsidiary of Leidos.
Leidos’ Benefits From the Acquisition
QTC provides more than 3,000 independent medical examinations and medical record reviews per day to key federal customers across 50 states. The buyout of IMX will boost Leidos’ capability of independent medical evaluations, medical record reviews, and medical and vocational case management for insurance carriers, employers, law firms, third-party administrators, and the state and local government.
According to the 2018 U.S. Census, between 2010 and 2030, the number of individuals aged 65+ is projected to increase from 39 million to 73 million, a growth rate nearly 5 times more than the 17% expected increase in total population. As life expectancy continues to increase in the United States and seniors account for a higher percentage of the total U.S. population, the overall demand for medical checkup and medical reviews is expected to increase.
Hence, the combined company will be able to provide medical evaluation services in the commercial market and Federal space.
Acquisition to Boost Revenues
Leidos’ Health business currently contributes nearly 18% to its entire business sales. We expect this acquisition to increase the share of revenues from Leidos’ health business over the long term.
Price Performance
In the past six months, shares of Leidos have gained 30.8% against the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.